Skip to main content

Table 4 Complications After Placement on VA ECMO of Non-Survivors and Survivors

From: Venoarterial extracorporeal membrane oxygenation for cardiac support in human immunodeficiency virus-positive patients: a case report and review of a multicentre registry

 

Non-Survivors (21)

Survivors (15)

p-value

Cardiovascular, n (%)

   

 Cardiac arrhythmia

3 (14)

1 (7)

0.6257

 CPR

3 (14)

0 (0)

0.25

 Vasopressor/Inotropes on VA ECMO

9 (42)

1 (7)

0.0245

 Myocardial stunning

3 (14)

0 (0)

0.25

Neurologic, n (%)

   

 Brain death

2 (10)

0 (0)

0.5

 CNS Infarction

1 (5)

0 (0)

1

Pulmonary, n (%)

   

 Pneumothorax requiring treatment

1 (5)

1 (7)

1

 Pulmonary haemorrhage

1 (5)

0 (0)

1

Renal, n (%)

   

 AKI

7 (33)

1 (7)

0.1038

 Renal Replacement Therapy

8 (38)

2 (13)

0.1422

Circuit complications, n (%)

   

 Thrombosis

1 (5)

6 (40)

0.0134

Other, n (%)

   

 Haemorrhage

3 (14)

4 (27)

0.4178

 Culture proven infection while on VA ECMO

4 (19)

2 (13)

1

 Hyperbilirubinemia

3 (14)

0 (0)

0.25

  1. *Vasopressor/inotropic drugs include Adrenaline, Noradrenaline, Vasopressin, Milrinone and Levosimendan and Vasoactive drug not specified.